50672-13-4Relevant articles and documents
ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS AND USES THEREOF
-
, (2016/01/01)
Disclosed are compounds of Formula (IVA), or a salt thereof, and pharmaceutical formulations (pharmaceutical compositions) comprising those compounds, or a salt thereof: Formula (IVA), wherein "RIa", "RIb", "RIc", "RId", "RIe", are defined herein above, which compounds are believed suitable for use in positive modulation of the alpha 7 nicotinic acetylcholine receptor (α7 nAChR) receptors, for example, those found in the cerebral cortex and the hippocampus. Such compounds and pharmaceutical formulations are believed to be useful in treatment or management of neurodegenerative diseases, for example, Alzheimer's disease (AD), schizophrenia, and Parkinson's disease (PD), or movement disorders arising from use of certain medications used in the treatment or management of Parkinson's disease.
N-(BENZIMIMDAZOL-2-YL)-CYCLOPROPANE CARBOXAMIDES AS LYSOPHOSPHATIDIC ACID ANTAGONISTS
-
Page/Page column 21; 22, (2013/03/26)
The invention provides novel substituted cyclopropane carboxamide compounds according to Formula (I), their manufacture and use for the treatment of proliferative inflammatory diseases, such as cancer, fibrosis or arthritis.
A TANDEM MICHAEL REACTION-CYCLOALKYLATION UTILIZING 2-NITROPROPANE: A FACILE ROUTE TO THE ACID COMPONENT OF INSECTICIDAL PYRETHROIDS
Babler, James H.,Spina, Kenneth P.
, p. 1923 - 1926 (2007/10/02)
Treatment of three representative β-substituted-α-cyanoacrylates (2) with 2-nitropropane and potassium carbonate in refluxing ethanol afforded stereoselectively cyclopropanoid precursors (4) to 3-substituted-2,2-dimethylcyclopropanecarboxylic acids (7).